Johns Hopkins Psychiatry Guide
Methadone
INDICATIONS
FDA
FDA
- Opioid-use disorder (OUD) – detoxification and maintenance treatment; severe and persistent pain requiring extended treatment and for which alternative options are inadequate
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 2, 2025
Citation
Weinstein, Sujin L. "Methadone." Johns Hopkins Psychiatry Guide, The Johns Hopkins University, 2025. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787454/10/Methadone.
Weinstein SL. Methadone. Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787454/10/Methadone. Accessed October 8, 2025.
Weinstein, S. L. (2025). Methadone. In Johns Hopkins Psychiatry Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787454/10/Methadone
Weinstein SL. Methadone [Internet]. In: Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. [cited 2025 October 08]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787454/10/Methadone.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Methadone
ID - 787454
A1 - Weinstein,Sujin,PharmD, BCPP
Y1 - 2025/10/02/
BT - Johns Hopkins Psychiatry Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787454/10/Methadone
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
